Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecovirimat for home-managed mpox
ISRCTN17461766Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Aug 2022
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in mpox comparing Tecovirimat with Placebo (2 arms). Primary endpoint: Time to active lesion resolution. Started Aug 2022; status: completed.
02
Drugs
tecovirimat
03
Conditions
mpox
Beyond the preview
Go deeper on ISRCTN17461766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17461766.